We are pleased to announce that our corporate website has been updated. This update includes a reorganization of information related to our business activities, along

Wellthera Co., Ltd. announces that, effective 30 November 2025, the company has completed a reduction of its share capital as outlined below.   Details of

On October 17, 2025, Mr. Hodaka Nakanishi resigned from his position as a Director of the Company. Accordingly, at the extraordinary general meeting of shareholders

Discover our innovative BUS-DDS platform and explore potential partnering opportunities at BioJapan 2025, held from October 8 (Wed) to October 10 (Fri) at Pacifico Yokohama.

Wellthera Co., Ltd. announces the following changes in its executive leadership, as approved at the Extraordinary General Meeting of Shareholders held on July 29, 2025.